TH1601006420A - The IGF-1R antibody and its use are referring to the drug for the treatment of cancer. - Google Patents

The IGF-1R antibody and its use are referring to the drug for the treatment of cancer.

Info

Publication number
TH1601006420A
TH1601006420A TH1601006420A TH1601006420A TH1601006420A TH 1601006420 A TH1601006420 A TH 1601006420A TH 1601006420 A TH1601006420 A TH 1601006420A TH 1601006420 A TH1601006420 A TH 1601006420A TH 1601006420 A TH1601006420 A TH 1601006420A
Authority
TH
Thailand
Prior art keywords
drug
igf
antibody
cancer
referring
Prior art date
Application number
TH1601006420A
Other languages
Thai (th)
Inventor
เกิทช์
ลิเลียน
โบรสแซส
แมทธิว
บู-ลาร์วอร์
ชาร์ล็อตต์
ชอมปิยอง
เธียร์รี่
โรเบิร์ต
อลัง
Original Assignee
นางดารานีย์ วัจนะวุฒิวงศ์
นางสาวสนธยา สังขพงศ์
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงศ์, นางสาวสนธยา สังขพงศ์ filed Critical นางดารานีย์ วัจนะวุฒิวงศ์
Publication of TH1601006420A publication Critical patent/TH1601006420A/en

Links

Claims (1)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แท็ก : สิทธิบัตรยา: Privilege (number one) that will appear on the advertisement page: Tag: drug patent
TH1601006420A 2015-04-27 The IGF-1R antibody and its use are referring to the drug for the treatment of cancer. TH1601006420A (en)

Publications (1)

Publication Number Publication Date
TH1601006420A true TH1601006420A (en) 2020-03-02

Family

ID=

Similar Documents

Publication Publication Date Title
TH1601006420A (en) The IGF-1R antibody and its use are referring to the drug for the treatment of cancer.
TH181796A (en) Angio-poitin-like-4 antibodies and methods of their use
TH178544A (en) Composition and method of application For enhanced immune response and cancer therapy
TH1701001929A (en) Substitudate aminopureine compounds, their constituents, and their treatment methods
TH180320A (en) Antiseptic-VISTA, Antibodies and Fragments
TH180367A (en) Antibody-IL-13 / IL- 17 Bspecific antibody and its use
TH1701003631A (en) Quinazoline derivatives used to treat HIV
TH1701006100A (en) Pyridopyrimidenone and its use
TH1701000860A (en) Antibody Antibody-TIGIT
TH1601003539A (en) The conjugate of ANT-HER2 antibody-drug
TH1701007724A (en)
TH179187A (en) Glycoconjugate Components for Immunosuppression / Therapy And using that
TH1501005539A (en) Heteroeryl compounds and their uses
TH181291A (en) Peptidomatic compounds and conjugate antibodies - the drug of that
TH179122A (en) Antibodies against CLL-1 and immunoconjugated
TH179638A (en) Antibodies against CD3 and how they are used
TH1501005024A (en) Pharmaceutical constituents for the treatment of fungal infections.
TH1601000340A (en) Composition of a carbohydrate vaccine for the inducing immune response and its use in cancer treatment.
TH1601003451A (en) Antibodies and methods of use
TH180268A (en) antibody
TH182881A (en) Composition for use in the treatment of anaphylaxis
TH1601003681A (en) Applications of isosazoline compounds in poultry
TH176529A (en) Antibody specific to FcRn
TH180751A (en) Antibody-CD52 Antibody
TH170459A (en) "The AAV-containing elements that express the dual antibody structure and their benefits"